CARDIOVASCULAR MEDICAL DEVICES: REGULATORY SCIENCE RESEARCH OVERVIEW IN THE OFFICE OF SCIENCE AND ENGINEERING LABORATORIES (OSEL) AT THE FOOD AND DRUG ADMINISTRATION (FDA)

被引：0

作者：

Aycock, Kenneth ^{[1
]}

Blinova, Ksenia ^{[1
]}

Casciola, Maura ^{[1
]}

Craven, Brent ^{[1
]}

Di Prima, Matthew ^{[1
]}

D'Souza, Gavin ^{[1
]}

Duraiswamy, Nandini ^{[1
]}

Farahmand, Masoud ^{[1
]}

Hariharan, Prasanna ^{[1
]}

Herbertson, Luke ^{[1
]}

Jamiolkowski, Megan ^{[1
]}

Lu, Qijin ^{[1
]}

Malinauskas, Richard ^{[1
]}

Patel, Mehulkumar ^{[1
]}

Rinaldi, Jean ^{[1
]}

Sivan, Shiril ^{[1
]}

Vesnovsky, Oleg ^{[1
]}

Weaver, Jason ^{[1
]}

机构：

[1] US FDA, Cardiovasc Res Grp, Ctr Devices & Radiol Hlth CDRH, OSEL, Silver Spring, MD 20993 USA

来源：

PROCEEDINGS OF THE 2021 DESIGN OF MEDICAL DEVICES CONFERENCE (DMD2021) | 2021年

基金：

美国国家科学基金会;

关键词：

FDA; OSEL; Cardiovascular; Hemocompatibility; Hemodynamics; Device Durability; Electrophysiology;

D O I：

暂无

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

The Cardiovascular Research Program in OSEL at the FDA consists of a diverse group of engineers and scientists who seek to drive innovation in cardiovascular device technology through development and standardization of pre-clinical test methods using in vitro, in vivo, and in silico models. The goal is to improve the pre- and post-market regulatory review processes and to accelerate patient access to safe and effective cardiovascular medical devices (e.g., heart valves, ventricular assist devices, cardiopulmonary bypass and cardiac mapping systems, ablation catheters, pacemakers, defibrillators, cardiac occluders, etc).

引用

页数：6

共 50 条

[1] Advancing Regulatory Science With Computational Modeling for Medical Devices at the FDA's Office of Science and Engineering Laboratories
Morrison, Tina M.
Pathmanathan, Pras
Adwan, Mariam
Margerrison, Edward
FRONTIERS IN MEDICINE, 2018, 5
[2] Working With the Food and Drug Administration's Center for Devices to Advance Regulatory Science and Medical Device Innovation
Malinauskas, Richard A.
Saha, Anindita
Sheldon, Murray I.
ARTIFICIAL ORGANS, 2015, 39 (04) : 293 - 299
[3] Advances in Regulatory Science at the Food and Drug Administration
Psaty, Bruce M.
Goodman, Steven N.
Breckenridge, Alasdair
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (20): : 2103 - 2104
[4] The food and drug administration office of Women's Health: Impact of science on regulatory policy
Obias-Manno, Dulce
Scott, Pamela E.
Kaczmarczyk, Joseph
Miller, Margaret
Pinnow, Ellen
Lee-Bishop, Lynda
Jones-London, Michelle
Chapman, Kennerly
Kallgren, Deborah
Uhl, Kathleen
JOURNAL OF WOMENS HEALTH, 2007, 16 (06) : 807 - 817
[5] Regulatory science within US Food and Drug Administration
Patwardhan, Dinesh
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[6] The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update
Elahi, Merina
Eshera, Noha
Bambata, Nkosazana
Barr, Helen
Lyn-Cook, Beverly
Beitz, Julie
Rios, Maria
Taylor, Deborah R.
Lightfoote, Marilyn
Hanafi, Nada
DeJager, Lowri
Wiesenfeld, Paddy
Scott, Pamela E.
Fadiran, Emmanuel O.
Henderson, Marsha B.
JOURNAL OF WOMENS HEALTH, 2016, 25 (03) : 222 - 234
[7] Advancing Regulatory Science to Bring Novel Medical Devices for Use in Emergency Care to Market: The Role of the Food and Drug Administration
Scully, Christopher G.
Forrest, Shawn
Galeotti, Loriano
Schwartz, Suzanne B.
Strauss, David G.
ANNALS OF EMERGENCY MEDICINE, 2015, 65 (04) : 400 - 403
[8] The Roles of Regulatory Science Research in Drug Development at the Pharmaceuticals and Medical Devices Agency of Japan
Asahina, Yasuko
Tanaka, Ayumi
Uyama, Yoshiaki
Kuramochi, Kenji
Maruyama, Hiroshi
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (01) : 19 - 22
[9] The Roles of Regulatory Science Research in Drug Development at the Pharmaceuticals and Medical Devices Agency of Japan
Yasuko Asahina
Ayumi Tanaka
Yoshiaki Uyama
Kenji Kuramochi
Hiroshi Maruyama
Therapeutic Innovation & Regulatory Science, 2013, 47 : 19 - 22
[10] Advanced science education in the regulatory arena: The Center for Drug Evaluation and research experience at the Food and Drug Administration
Ajayi, FO
Wilcox, DF
Uhl, K
Quinn, J
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (07): : 711 - 717

← 1 2 3 4 5 →